Form 4: Diane Holder Receives Restricted Stock Units in Evolent Health, Inc.

Director Diane Holder received 7,709 restricted stock units of Evolent Health, Inc. on June 6, 2024, under the company's 2015 Omnibus Incentive Compensation Plan.

Summary

• On June 6, 2024, Diane Holder, a director of Evolent Health, Inc., was granted 7,709 restricted stock units (RSUs).
• These RSUs were granted under the company's 2015 Omnibus Incentive Compensation Plan.
• The RSUs will vest on the earlier of June 6, 2025, or the date of the company's 2025 annual meeting, contingent upon Ms. Holder's continued service.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects a standard compensation practice that aligns director interests with shareholder value. There are no indications of negative implications.

Positives

• The grant of restricted stock units aligns Ms. Holder's interests with those of the company and its shareholders.
• The vesting schedule incentivizes continued service and contribution to Evolent Health, Inc.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the restricted stock units.

Industry Context

This type of equity compensation is common for directors and executives in publicly traded companies to align their interests with shareholders and incentivize performance.

Stakeholder Impact

• Shareholders may view the grant positively as it aligns the director's interests with the company's long-term success.
• The director is incentivized to contribute to the company's growth and profitability.

Key Dates